Contacts: Investors Traci McCarty BioMarin Pharmaceutical Inc[removed]

First Page		Document Content
Genetic genealogy BioMarin Pharmaceutical Duchenne muscular dystrophy Dystrophin 3 4-Diaminopyridine Mucopolysaccharidosis Morquio syndrome Tetrahydrobiopterin Muscular dystrophy Health Biology		Contacts: Investors Traci McCarty BioMarin Pharmaceutical Inc[removed] Add to Reading List Source URL: files.shareholder.com Download Document from Source Website File Size: 354,45 KB Share Document on Facebook

	July 13, 2016 Post-Grant for Practitioners Midyear Review of Decisions and Developments at the PTAB DocID: 1q9UZ - View Document
	United States Court of Appeals for the Federal Circuit ______________________ GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP, DocID: 1oYEH - View Document
	ROUNDTABLE SURVEY RESULTS Our pilot program in 2015 was very successful. We distributed and collected surveys from all 6 of our Roundtable events, which were held in Boston, MA, Pittsburgh, PA. Los Angeles, CA and Dubl DocID: 1oCyv - View Document
	Contacts: Investors Traci McCarty BioMarin Pharmaceutical Inc DocID: 1cPVY - View Document
	Privacy Policy and Notice of Information Practices Effective Date: April 27, 2015 BioMarin Pharmaceutical Inc. ("BioMarin") respects the privacy of visitors to its websites and online services and values the confidence o DocID: 1aV9H - View Document